Literature DB >> 173445

In situ intraduct carcinoma of the breast: a long term follow-up study.

R R Millis, G S Thynne.   

Abstract

Twenty-eight patients with in situ intraduct carcinoma of the breast are reviewed. Two patients had bilateral tumours. The numbers of patients treated by wide local excision, simple mastectomy and mastectomy with axillary dissection were approximately equal; none of these patients died of carcinoma. The conclusions regarding prognosis and treatment of in situ intraduct carcinoma of the breast are discussed.

Entities:  

Mesh：

Year:  1975        PMID： 173445     DOI： 10.1002/bjs.1800621209

Source DB:  PubMed          Journal:  Br J Surg        ISSN： 0007-1323            Impact factor:   6.939


  12 in total

1.  Radiotherapy for ductal carcinoma in situ detected by screening.

Authors:  C R Hamilton; R B Buchanan
Journal:  BMJ       Date:  1990-07-28

2.  [Prognostic factors in ductal carcinoma in situ].

Authors:  A Lebeau
Journal:  Pathologe       Date:  2006-09       Impact factor: 1.011

Review 3.  Benign breast disease in the postmenopausal woman.

Authors:  J E Devitt
Journal:  World J Surg       Date:  1989 Nov-Dec       Impact factor: 3.352

Review 4.  Management of in situ and minimally invasive breast carcinoma.

Authors:  E R Frykberg; K I Bland
Journal:  World J Surg       Date:  1994 Jan-Feb       Impact factor: 3.352

5.  Noninvasive breast carcinoma: results of a national survey by the American College of Surgeons.

Authors:  D Rosner; R N Bedwani; J Vana; H W Baker; G P Murphy
Journal:  Ann Surg       Date:  1980-08       Impact factor: 12.969

6.  Pathobiology of breast cancer: hypothesis of biological predetermination and long-term survival.

Authors:  H Vorherr
Journal:  Klin Wochenschr       Date:  1981-08-03

Review 7.  The role of radiotherapy in the conservative treatment of ductal carcinoma in situ of the breast.

Authors:  Csaba Polgár; Zsuzsanna Kahán; Zsolt Orosz; Gabriella Gábor; Janaki Hadijev; Gábor Cserni; Janina Kulka; Nóra Jani; Zoltán Sulyok; György Lázár; Gábor Boross; Csaba Diczházi; Eva Szabó; Zsolt László; Zoltán Péntek; Tibor Major; János Fodor
Journal:  Pathol Oncol Res       Date:  2008-04-26       Impact factor: 3.201

8.  Prognostic variables in invasive breast cancer: contribution of comedo versus noncomedo in situ component.

Authors:  S T Brower; S Ahmed; P I Tartter; I Bleiweiss; J B Amberson
Journal:  Ann Surg Oncol       Date:  1995-09       Impact factor: 5.344

9.  Tumor cell budding from focally disrupted tumor capsules: a common pathway for all breast cancer subtype derived invasion?

Authors:  Yan-Gao Man
Journal:  J Cancer       Date:  2010-06-02       Impact factor: 4.207

10.  c-erbB-2 expression in benign and malignant breast disease.

Authors:  B A Gusterson; L G Machin; W J Gullick; N M Gibbs; T J Powles; C Elliott; S Ashley; P Monaghan; S Harrison
Journal:  Br J Cancer       Date:  1988-10       Impact factor: 7.640
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.